Field evaluation of xpert HPV point-of-care test for detection of human papillomavirus infection by use of self-collected vaginal and clinician-collected cervical specimens

Journal of Clinical Microbiology

Volumn 54, Issue 7, 2016, Pages 1734-1737

  Toliman, P ^a   Badman, S G ^b   Gabuzzi, J ^a   Silim, S ^a   Forereme, L ^c   Kumbia, A ^c   Kombuk, B ^d   Kombati, Z ^d   Allan, J ^a   Munnull, G ^a   Ryan, C ^e   Vallely, L M ^a,b   Kelly Hanku, A ^a,f   Wand, H ^b   Mola, G D L ^g   Guy, R ^b   Siba, P ^a   Kaldor, J M ^b   Tabrizi, S N ^h,i   Vallely, A J ^a,b  

^a PAPUA NEW GUINEA INSTITUTE OF MEDICAL RESEARCH   (Papua New Guinea)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

^c Eastern Highlands Provincial Hospital   (Papua New Guinea)

^d Mount Hagen Hospital   (Papua New Guinea)

^e BURNET INSTITUTE   (Australia)

^f UNIVERSITY OF NEW SOUTH WALES   (Australia)

^g UNIVERSITY OF PAPUA NEW GUINEA   (Papua New Guinea)

^h ROYAL WOMEN'S HOSPITAL   (Australia)

ⁱ UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CLINICAL EVALUATION; CRYOTHERAPY; FEMALE; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; HUMAN PAPILLOMAVIRUS TYPE 45; MAJOR CLINICAL STUDY; NONHUMAN; PAPILLOMAVIRUS INFECTION; POINT OF CARE TESTING; PRIORITY JOURNAL; UTERINE CERVICITIS; VAGINITIS; WOMEN'S HEALTH; COMPARATIVE STUDY; EARLY CANCER DIAGNOSIS; EVALUATION STUDY; ISOLATION AND PURIFICATION; MIDDLE AGED; MOLECULAR DIAGNOSIS; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PAPUA NEW GUINEA; POINT OF CARE SYSTEM; PROCEDURES; SPECIMEN HANDLING;

ADULT; EARLY DETECTION OF CANCER; FEMALE; HUMANS; MIDDLE AGED; MOLECULAR DIAGNOSTIC TECHNIQUES; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PAPUA NEW GUINEA; POINT-OF-CARE SYSTEMS; SPECIMEN HANDLING;

EID: 84976350936     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.00529-16     Document Type: Article

References (16)

1. Nanda K, McCrory DC, Myers ER, Bastian LA, Hasselblad V, Hickey JD, Matchar DB. 2000. Accuracy of the Papanicolaou test in screening for and follow-up of cervical cytologic abnormalities: a systematic review. Ann Intern Med 132:810-819. http://dx. doi. org/10. 7326/0003-4819-132-10-200005160-00009.
2. Einstein MH, Smith KM, Davis TE, Schmeler KM, Ferris DG, Savage AH, Gray JE, Stoler MH, Wright TC, Jr, Ferenczy A, Castle PE. 2014. Clinical evaluation of the cartridge-based GeneXpert human papillomavirus assay in women referred for colposcopy. J Clin Microbiol 52:2089-2095. http://dx. doi. org/10. 1128/JCM. 00176-14.
3. Dillner J, Rebolj M, Birembaut P, Petry KU, Szarewski A, Munk C, de Sanjose S, Naucler P, Lloveras B, Kjaer S, Cuzick J, van Ballegooijen M, Clavel C, Iftner T. 2008. Long term predictive values of cytology and human papillomavirus testing in cervical cancer screening: joint European cohort study. BMJ 337:a1754. http://dx. doi. org/10. 1136/bmj. a1754.
4. Sankaranarayanan R, Nene BM, Shastri SS, Jayant K, Muwonge R, Budukh AM, Hingmire S, Malvi SG, Thorat R, Kothari A, Chinoy R, Kelkar R, Kane S, Desai S, Keskar VR, Rajeshwarkar R, Panse N, Dinshaw KA. 2009. HPV screening for cervical cancer in rural India. N Engl J Med 360:1385-1394. http://dx. doi. org/10. 1056/NEJMoa0808516.
5. Rijkaart DC, Berkhof J, Rozendaal L, van Kemenade FJ, Bulkmans NW, Heideman DA, Kenter GG, Cuzick J, Snijders PJ, Meijer CJ. 2012. Human papillomavirus testing for the detection of high-grade cervical intraepithelial neoplasia and cancer: final results of the POBASCAM randomised controlled trial. Lancet Oncol 13:78-88. http://dx. doi. org/10.1016/S1470-2045(11)70296-0.
6. Canfell K. 2015. Compass-a randomised controlled trial of HPV screening in Australia, abstr 8. Abstr Prev Cervical Cancer 2015 Conf, Melbourne, Australia, 20 to 22 February 2015.
7. Australian Government Department of Health. 2014. National Cervical Screening Program. Overview of the renewal. Australian Government Department of Health, Canberra, ACT, Australia. http://www.cancerscreening. gov. au/internet/screening/publishing. nsf/Content/overview-of-the-renewal. Accessed 14 January 2015.
8. WHO. 2013. WHO guidelines for screening and treatment of precancerous lesions for cervical cancer prevention. World Health Organization, Geneva, Switzerland.
9. Castle PE, Smith KM, Davis TE, Schmeler KM, Ferris DG, Savage AH, Gray JE, Stoler MH, Wright TC, Jr, Ferenczy A, Einstein MH. 2015. Reliability of the Xpert HPV assay to detect high-risk human papillomavirusDNAin a colposcopy referral population. AmJ Clin Pathol 143:126-133. http://dx. doi. org/10. 1309/AJCP4Q0NSDHWIZGU.
10. Tabrizi SN, Unemo M, Golparian D, Twin J, Limnios AE, Lahra M, Guy R. 2013. Analytical evaluation of GeneXpert CT/NG, the first genetic point-of-care assay for simultaneous detection of Neisseria gonorrhoeae and Chlamydia trachomatis. J Clin Microbiol 51:1945-1947. http://dx. doi.org/10. 1128/JCM. 00806-13.
11. WHO, IARC. 2015. GLOBOCAN 2012: estimated cancer incidence, mortality and prevalence worldwide in 2012. http://globocan. iarc. fr/Pages/fact-sheets-population. aspx. World Health Organization, Geneva, Switzerland.
12. Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A. 4 February 2015. Global cancer statistics, 2012. CA Cancer J Clin http://dx.doi. org/10. 3322/caac. 21262.
13. Vallely A, Mola GD, Kaldor JM. 2011. Achieving control of cervical cancer in Papua New Guinea: what are the research and program priorities? P N G Med J 54:83-90.
14. FDA. 2007. Statistical guidance on reporting results from studies evaluating diagnostic tests. Food and Drug Administration, US Department of Health and Human Services, Rockville, M.D.
15. Landis JR, Koch GG. 1977. The measurement of observer agreement for categorical data. Biometrics 33:159-174. http://dx. doi. org/10. 2307/2529310.
16. Arbyn M, Verdoodt F, Snijders PJ, Verhoef VM, Suonio E, Dillner L, Minozzi S, Bellisario C, Banzi R, Zhao FH, Hillemanns P, Anttila A. 2014. Accuracy of human papillomavirus testing on self-collected versus clinician-collected samples: a meta-analysis. Lancet Oncol 15:172-183. http://dx. doi. org/10. 1016/S1470-2045(13)70570-9.